Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study
Journal of Clinical Medicine · 19.02.2026 · 15 (4) · 1607
DOI: 10.3390/jcm15041607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.02.2026. Verfasst von Liviu Moraru und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine, Pharmacy, Science and Technology “GE Palade” (UMFST) from Targu-Mures Romania.
Abstract (Originalsprache)
Pre-eclampsia (PE) is a multisystem disorder that affects 5–6% of all pregnancies.
Background
PE and intrauterine growth restriction (IUGR) are two major causes of maternal mortality and morbidity. We hypothesize that first-trimester pregnancy-associated plasma protein-A (PAPP-A) levels are useful as a prognostic marker. The aim of our study is to identify the role of PAPP-A and placental thickness in pre-eclampsia screening, as well as its value in IUGR prognosis.
Methods
This prospective study was conducted at the Al. Simionescu County Hospital Hunedoara, Romania, Department of Obstetrics and Gynecology, from 12 May to 31 October 2025. A total of 102 patients were included in our study; of these, 28 patients (28.56%) developed pre-eclampsia, and 13 (13.26%) developed IUGR associated with PE.
Results
The demographic data showed no differences between groups, except for BMI, smoking habits, and diabetes mellitus. Of the 28 cases of pre-eclampsia, 14.28% had PE detected by 28 weeks, 46.4% had PE associated with IUGR by 33/34 weeks, and 39.32% had PE detected at term/delivery. The highest detection rate was at 33/34 weeks, when the association with IUGR was obvious. For PE with IUGR at 34 weeks, the area under the curve (AUC) was 0.909, with a p-value < 0.001. The PAPP-A cut-off was 0.65 MoM, indicating high sensitivity and specificity for predicting PE. Placental thickness was also assessed, resulting in statistically significant differences between groups. The PAPP-A level shows strong predictive value for PE, especially when associated with placental thickness.
Conclusions
This study demonstrates a clear correlation between low PAPP-A in the first trimester of pregnancy, placental thickness in the second trimester, and the subsequent development of pre-eclampsia and its association with IUGR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.
- Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Department of Obstetrics and Gynecology, University of Medicine and Pharmacy Iuliu Hatieganu, 400347 Cluj-Napoca, Romania.
ORCID-Profile: Melinda Ildiko Mitranovici, Romeo Micu
Förderung
- University of Medicine, Pharmacy, Science and Technology “GE Palade” (UMFST) from Targu-Mures Romania
Zitieren
APA
Moraru, L., Moraru, R., Mitranovici, M. I., & Micu, R. (2026). Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study. Journal of Clinical Medicine, 15(4), 1607. https://doi.org/10.3390/jcm15041607
Vancouver
Moraru L, Moraru R, Mitranovici MI, Micu R. Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study. Journal of Clinical Medicine. 2026;15(4):1607. doi:10.3390/jcm15041607
BibTeX
@article{Moraru2026,
author = {Moraru, Liviu and Moraru, Raluca and Mitranovici, Melinda Ildiko and Micu, Romeo},
title = {Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {4},
pages = {1607},
doi = {10.3390/jcm15041607}
}
EUVIMED